Besides its role in calcium and skeletal homeostasis, 1,25-dihydroxyvitamin D3 [1, 25(OH) 2D3] plays a widespread role in the differentiation, proliferation, biosynthetic activity, and function of cells of the immune system (1) . Its effects on lymphocytes are mediated by the specific 1,25(OH)2D3 receptor, a ligand-dependent transcription factor that recognizes DNA elements in the promoters of its target genes, termed vitamin D response elements (VDREs). Nonetheless, VDREs are not present in the regulatory sequences of genes influenced by 1,25(OH)2D3 in lymphocytes. Further, the effects of 1,25(OH)2D3 on lymphocytes are pleiotropic and depend on the mode of activation (1) . Based on these considerations, we have hypothesized that 1,25(OH)2D3 exerts its actions on lymphocyte products through interactions with other factors generated following activation, rather than through direct interaction of its receptor with these genes. A precedent for modulation of gene expression by a steroid hormone through influencing other transcription factors has been set in the case of the glucocorticoid receptor (2, 3) .
Nuclear factor K B (NF-KB) designates a family of structurally and functionally related protein complexes used by lymphoid cells to regulate genes encoding products that participate in the immune response (4) . All members of the family share a 300-amino acid region of homology that mediates dimerization and high-affinity binding to decameric DNA sequences of the consensus 5'-GGGRNNYYCC-3' (where R is purine and Y is pyrimidine) (5) . The ability of NF-KB to bind DNA is controlled by protein-protein interactions with highly specific inhibitor proteins, termed IKB (6) . Association with IKB prevents nuclear uptake by retaining NF-KB complexes in the cytoplasm. Stimulation with various agents causes the release of IKB from the rel-NF-KB complexes, thus allowing the rapid translocation of rel-NF-KB into the nucleus.
The prototypical NF-KB is composed of two distinct subunits of 50 kDa and 65 kDa referred to as p50 and p65 or RelA, respectively. The p5O subunit is synthesized as a 105-kDa protein, p105, that undergoes posttranslational processing to the mature form (7, 8) . c-rel, the normal cellular homolog of the oncogene product of the avian reticuloendotheliosis virus REV-T v-rel, is another member of the NF-KB family that is expressed in mammalian cells (9) . p50, c-rel, and p65 are in fact the major components of NF-KB complexes, binding to most of the identified cis-acting KB sites. All these proteins are expressed in various cells, but most abundantly in differentiated human lymphoid cell lines and human peripheral blood resting B and activated T cells (4, 10) . Though all of them are constitutively expressed, their expression is up-regulated by NF-KB-activated conditions such as those occurring during stimulation of T cells or B cells (11) .
Control of the activation of preexisting forms of NF-KB has attracted large attention. However, relatively little is known about the regulation of the level of expression of the various NF-KB proteins themselves. In this report, we present evidence indicating that during normal T-cell activation in vitro, there is a progressive increase in the levels of p50, its plO5 precursor, and c-rel and that 1,25(OH)2D3 acts to down-regulate the levels of these proteins and thereby decrease their transcriptional activity in human lymphocytes. *To whom reprint requests should be addressed.
EXPERIMENTAL PROCEDURES
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (Fig. 1) , isolation of nuclear fractions was performed as described (16) . All buffers contained 0.5 mM PMSF, 1 mg of leupeptin per ml, 0.5 mg of pepstatin per ml, and 1 mg of aprotinin per ml. Briefly, 4-6 x 107 cells were washed with hypotonic buffer (10 mM Hepes, pH 7.9/1.5 mM MgCl2/10 mM KCl/0.5 mM dithiothreitol) and lysed for 10 min on ice in hypotonic buffer containing 0.1% Nonidet P-40 (30 ,ul per 107 cells). Lysates were centrifuged (10,000 x g) at 4°C for 10 min. Supernatants were collected and centrifuged at 100,000 x g at 4°C, and the resulting high-speed supernatant was used as the cytosolic fraction. Pelleted nuclei were resuspended in 100 Aul of lysis buffer (20 mM Hepes, pH 7.9/420 mM NaCl/1.5 mM MgCl2/0.2 mM EDTA/25% glycerol) and incubated at 4°C for 15 min. Lysed nuclei were dispersed in a Vortex and centrifuged at 10,000 X g, 4°C for 10 min; supernatants were collected, snap-frozen, and stored at -70°C. Protein concentrations of nuclear and cytosolic fractions were determined by the method of Bradford (17) .
Western Blot Analysis. Protein extracts (100 ,ug per lane) were electrophoresed on SDS/polyacrylamide (7.5%) gels (18) , transferred to nitrocellulose membranes, and immunoblotted with the indicated antibodies as described (15) . Radioactivity of the bands was determined using a ,B scanner (AMBIS Systems). Background was subtracted from each lane.
Electrophoretic Mobility Shift Assay. Nuclear extracts from lymphocytes were prepared as described above. A synthetic double-stranded oligonucleotide containing the NF-KB binding sequence of the human interleukin 6 (IL-6) promoter (-82 bp to -47 bp, 5'-ATCAAATGTGGGATTTTCCCAT-GAGTCTCAATATTA-3') was end-labeled using [y-32P]ATP and T4 polynucleotide kinase. One nanogram of end-labeled probe was incubated for 20 min at room temperature with 5 jig of nuclear protein in a solution containing 50 ,ug of poly(dIdC) per ml, 50 ,ug of double-stranded salmon sperm DNA per ml, 6% glycerol, 10 mM Hepes (pH 7.5), 80 mM KCl, 1 mM EDTA, and 1 mM EGTA. Competition studies were performed by incubating nuclear extracts with unlabeled NF-KB oligonucleotide or a 22-mer oligonucleotide containing an AP-1 binding motif (5'-CTAGTGATGAGTCAGCCGG ATC-3') for 15 min at room temperature (as indicated in Fig.   5 ), followed by a 30-min incubation in the presence of the probe. Samples were analyzed on native 5% polyacrylamide gels.
Transfection and CAT Assay. 
RESULTS
Analysis of the expression of NF-KB, prior to and during activation of normal human PBMCs with PHA over a period of 72 hr, was performed using an Ab (SP1157) recognizing the p5O subunit of NF-KB as well as the p105 precursor of this protein (13) (Fig. 1) . In either the cytosolic or the nuclear fraction, p5O or p105 was undetectable prior to or following 12 hr of activation. However, following 24 hr of activation, the p5O was detected in both fractions. Thereafter, its expression increased progressively. Activation also led to the appearance of the p105 precursor of p5O in the cytosol and the levels of this protein increased progressively during the activation period. In this particular experiment, the intensity of the p105 signal appearqd weaker than that of the p5O; however, this was not a consistent finding in subsequent experiments. Addition of 10-8 M 1,25(OH)2D3 simultaneously with addition of PHA caused a significant decrease in the expression of p5O at all time points examined. A similar effect was observed in the cytosolic and the nuclear fractions. In addition, 1,25(OH)2D3 decreased the expression of the p105 precursor of p5O in the cytosolic fraction.
Vitamin D metabolites with lesser potency [and lower affinity for the 1,25(OH)2D3 receptor] had no appreciable effects on the level of expression of NF-KB following a 72-hr activation with PHA (Fig. 2) . Nonetheless, the synthetic glucocorticoid TRM also inhibited NF-KB expression. In this experiment and that shown in Fig. 3 , as opposed to the data shown in Fig. 1 (Fig. 3) . The inhibiting effect of 1,25(OH)2D3 on p50 and p105 was apparent when the hormone was added simultaneously with PHA or 24, 48, or 64 hr following addition of PHA. However, when 1,25(OH)2D3 was added into the culture for the last 4 hr (68 hr following PHA activation) or the last 2 hr (70 hr following PHA activation) of the 72-hr culture period, there was no discernible effect. As shown in Fig. 3 (lower panel) Unstimulated lymphocytes used for the PHA activation experiment had no detectable c-rel; however, small levels of c-rel were present in the preparation used for the OKT3 activation experiment, perhaps reflecting an interindividual variation in the number of in vivo (or during the isolation procedure) activated cells, similar to the situation we had observed in the preparations used for the experiments shown in Figs. 1-3 The inhibiting effect of 1,25(OH)2D3 on NF-KB expression was confirmed with electrophoretic mobility shift assays using a synthetic oligonucleotide corresponding to the NF-KB response element (from the human IL-6 gene promoter) (Fig. 5) (Fig. 6) . To do this, we transiently transfected the T-lymphocytic cell line Jurkat [which expresses the 1,25(OH)2D3 receptor constitutively-i.e., without the requirement of activation (20)] with a construct containing the CAT gene under the regulatory control of the NF-KB consensus sequence that is present in the immunoglobulin K light chain gene. Stimulation of the Jurkat cells for 8 hr with PHA resulted in an increase in the NF-KB-driven CAT expression. In the presence of 1,25(OH)2-D3, the increase in CAT activity was partially inhibited (39% ± 14%). Similar results (41% ± 5% inhibition as compared to untreated cells) were obtained in a separate experiment. DISCUSSION These studies demonstrate that the abundance of p5O, as well as its p105 precursor, and c-rel increase progressively during prolonged lymphocyte activation and that 1,25(OH)2D3 downregulates these phenomena. Earlier studies had shown that the levels of the mRNA of genes encoding NF-KB subunits, including the p50 and c-rel, are enhanced in response to external stimuli such as antigens, cytokines, phorbol esters, and lectins (8, (21) (22) (23) (24) . In addition, observations by Hohmann et al. (25) Hass et al. (29) have shown that glucocorticosteroids inhibited phorbol 12-myristate 13-acetate-induced transient increase in NF-KB mRNA levels in the monocytic cell line U937 (29) . Taken together, these observations raise the possibility that steroid hormones with widespread regulatory influences on a large variety of genes might be exerting part of their actions, indirectly, through their ability to modulate the expression of ubiquitous transcription factors, such as NF-KB.
